Form 4: Recursion Pharmaceuticals Director Acquires Shares Under Compensation Policy

Director Terry-Ann Burrell acquired 1,467 shares of Recursion Pharmaceuticals' Class A Common Stock on April 1, 2024, under the company's Outside Director Compensation Policy.

Summary

• On April 1, 2024, Terry-Ann Burrell, a director of Recursion Pharmaceuticals, acquired 1,467 shares of Class A Common Stock.
• The acquisition was made under the Issuer's Outside Director Compensation Policy.
• Following the transaction, Burrell directly owns 56,314 shares of Recursion Pharmaceuticals.
• The transaction was reported on April 3, 2024.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transaction is part of a standard compensation policy and doesn't indicate significant positive or negative news.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Industry Context

Director share acquisitions are common and often tied to compensation policies, aligning director interests with shareholder value.

Stakeholder Impact

• The transaction has a minor positive impact on stakeholders by aligning director interests with shareholders.

Key Dates